Theravance Biopharma (TBPH) Shares Issued: 2013-2025
Historic Shares Issued for Theravance Biopharma (TBPH) over the last 6 years, with Sep 2025 value amounting to $258,000.
- Theravance Biopharma's Shares Issued was N/A to $258,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $584,000, marking a year-over-year change of. This contributed to the annual value of $508,000 for FY2024, which is 17.80% down from last year.
- Latest data reveals that Theravance Biopharma reported Shares Issued of $258,000 as of Q3 2025, which was up 1,190.00% from $20,000 recorded in Q1 2025.
- In the past 5 years, Theravance Biopharma's Shares Issued registered a high of $108.2 million during Q2 2021, and its lowest value of -$1,000 during Q3 2023.
- For the 3-year period, Theravance Biopharma's Shares Issued averaged around $116,600, with its median value being $133,000 (2024).
- Data for Theravance Biopharma's Shares Issued shows a maximum YoY slumped of 200.00% (in 2023) over the last 5 years.
- Theravance Biopharma's Shares Issued (Quarterly) stood at $108.2 million in 2021, then reached $314,000 in 2022, then tumbled by 44.90% to $173,000 in 2023, then declined by 23.12% to $133,000 in 2024, then reached $258,000 in 2025.
- Its last three reported values are $258,000 in Q3 2025, $20,000 for Q1 2025, and $133,000 during Q4 2024.